Purpose
|
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma as well as non-small cell lung cancer.
|
Characteristics
|
Tradename: LY-231514 Source of Compound: synthetic Target: DHFR inhibitor Receptor: TS, DHFR,GARFT and AICARFT,DHFR,TS
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
97?%
|
Formula
|
C20H19N5Na2O6
|
Solubility
|
Water 94 mg/mL,DMSO <1 mg="" ml="" <="" td="">
1> |